US Patent Family Members and Approved Drugs for Russian Federation Patent: 2221807
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Russian Federation Patent: RU2221807
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2019-03-01 | ibritumomab tiuxetan | Acrotech Biopharma Llc | ZEVALIN |
| ⤷ Get Started Free | 2019-03-01 | ibritumomab tiuxetan | Acrotech Biopharma Llc | ZEVALIN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
